Agilus Diagnostics is proud to announce the installation of the Rapid NGS Genexus System at its Gurugram Reference Laboratory, further strengthening its capabilities in advanced molecular diagnostics.
With this expansion, Agilus introduces its 3-Day Oncogenomics offering — providing clinicians with comprehensive, precision hemato-oncology insights using the Oncomine Myeloid NGS Panel, all within just three days. This rapid turnaround supports timely, data-driven decisions in the management of myeloid malignancies.
This milestone reflects Agilus Diagnostics’ continued commitment to delivering faster and more accurate results through cutting-edge technology, advancing the standard of patient care across India.
As a trusted partner to clinicians, Agilus remains committed to pushing the boundaries of diagnostic innovation to improve outcomes for every patient.